RBC Capital Downgrades CG Oncology to Sector Perform, Raises Price Target to $97

Benzinga · 19h ago
RBC Capital analyst Leonid Timashev downgrades CG Oncology (NASDAQ:CGON) from Outperform to Sector Perform and raises the price target from $80 to $97.